niraparib 100 mg (Zejula 100 mg)
Generic Name: niraparib
Pill with imprint niraparib 100 mg is Purple / White, Capsule-shape and has been identified as Zejula 100 mg. It is supplied by Tesaro Inc..
Zejula is used in the treatment of ovarian cancer; peritoneal cancer; fallopian tube cancer and belongs to the drug class PARP inhibitors. Zejula 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for niraparib 100 mg
Zejula
- Generic Name
- niraparib
- Imprint
- niraparib 100 mg
- Strength
- 100 mg
- Color
- Purple / White
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Parp inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Tesaro Inc.
- National Drug Code (NDC)
- 69656-0103
- Inactive Ingredients
-
magnesium stearate,
lactose monohydrate,
titanium dioxide,
gelatin hydrolysate (porcine skin, mw 3000),
FD&C Blue No. 1,
FD&C Red No. 3,
FD&C Yellow No. 5
Note: Inactive ingredients may vary.
More about Zejula (niraparib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 34 Reviews
- Drug class: PARP inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.